Individualized Duration of Peg-interferon/Ribavirin Treatment of Hepatitis C

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of the study is to investigate if the duration of treatment of hepatitis C with pegylated interferon and ribavirin can be individualized on the basis of how fast the hepatitis C virus concentration in the blood decreases, and if this is more cost-efficient than standard treatment.
Epistemonikos ID: cd0f603ae98ec2384dcd0bf85417fddc57f06d43
First added on: May 05, 2024